Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial (Q43610373)

25 November 2017

title

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial (English)

1 reference

25 November 2017

0 references

myocardial infarction

1 reference

1 reference

ventricular dysfunction

1 reference

H J Dargie

1

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

25 November 2017

volume

357

1 reference

25 November 2017

issue

9266

1 reference

25 November 2017

page(s)

1385-1390

1 reference

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904560-8

7 January 2021

10.1016/S0140-6736(00)04560-8

Identifiers

DOI

1 reference

25 November 2017

1 reference